Psilocybin for major depression granted Breakthrough Therapy by FDA

The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).
Read more: https://newatlas.com/science/psilocybin-major-depression-mdd-usona-breakthrough-therapy-fda/?source=Snapzu